Physician profile
Evis Petrela
NPI 1225200900
$6,012.64
in general payments reported to CMS, 2019-2025
29 companies · $2,438 in 2025
The $2,438 reported for 2025 was more than what 90% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $502 · 2020: $196 · 2021: $490 · 2022: $686 · 2023: $834 · 2024: $867 · 2025: $2,438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,163 · Charitable Contribution: $977.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,162.63 |
| Charitable Contribution | $976.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,230.12 | 2019-2025 | Rocklatan, Clareon, Clareon Panoptix Pro |
| Microsurgical Technology, INC. | $976.56 | 2025 | |
| Sight Sciences, INC. | $634.30 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Abbvie INC. | $549.32 | 2022-2025 | |
| Glaukos Corporation | $273.09 | 2019-2025 | Idosetr, Istent |
| Bausch & Lomb Americas INC. | $175.75 | 2023-2025 | Vyzulta, Miebo, Prolensa |
| Ivantis, INC | $150.28 | 2021 | |
| Sun Pharmaceutical Industries INC. | $123.40 | 2023-2025 | Cequa |
| Ocular Therapeutix, INC. | $120.61 | 2023-2025 | Dextenza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $115.64 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $100.33 | 2019-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $81.05 | 2019-2025 | Tecnis Simplicity |
| Dompe US, INC. | $72.02 | 2024-2025 | Oxervate |
| Biotissue Holdings INC. | $60.16 | 2020-2023 | |
| New World Medical,INC. | $42.17 | 2023-2024 | Streamline, Ahmed Glaucoma Valve, Clearpath |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $31.86 | 2023-2024 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Amgen INC. | $29.91 | 2025 | Tepezza |
| Harrow Eye, LLC | $27.93 | 2023-2025 | Vevye, Iheezo |
| Tarsus Pharmaceuticals, INC. | $27.29 | 2024 | Xdemvy |
| Oyster Point Pharma, INC. | $26.94 | 2024 | Ryzumvi, Tyrvaya |
| Horizon Therapeutics Plc | $23.83 | 2022 | |
| Kala Pharmaceuticals, INC. | $23.60 | 2022 | |
| Rxsight INC | $19.44 | 2024 | Rxsight Injector Cartridge, Rxsight Injector Handpiece, Rxsight Contact Lens |
| Mallinckrodt Enterprises LLC | $18.68 | 2019 | |
| Thea Pharma INC. | $17.96 | 2024 | Iyuzeh |
| Allergan, INC. | $17.53 | 2019 | |
| Shire North American Group INC | $16.08 | 2019 | |
| Aerie Pharmaceuticals, INC. | $13.42 | 2019 | |
| Eyevance Pharmaceuticals LLC | $13.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evis Petrela listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.